If you invested a modest $1,000 into shares of  Fulgent Genetics  (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec… Fulgent Genetics, Inc. has a market cap of $1.11 Billion and is expected to release its quarterly earnings report on November 09, 2020. Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. Are you researching Fulgent Genetics (NASDAQ:FLGT) stock for your portfolio? Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. The Motley Fool. On the other hand, the stock is +63.89% away from its low in the 90-day period. Source: FactSet. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Fulgent Genetics, Inc. (NASDAQ:FLGT) COO Jian Xie sold 1,000 shares of the stock in a transaction dated Wednesday, December 2nd. Copyright © 2020 MarketWatch, Inc. All rights reserved. … This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser. See Fulgent Genetics, Inc. (FLGT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. FULGENT GENETICS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for FULGENT GENETICS, INC. Stock | FLGT | Change value during other periods is calculated as the difference between the last trade and the most recent settle. Intraday data delayed at least 15 minutes or per exchange requirements. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. Is Fulgent Genetics Stock a Buy? Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. FLGT is not currently paying a regular dividend. Trending now. Historical and current end-of-day data provided by FACTSET. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Privacy Notice, and The Motley Fool. Copyright 2019© FactSet Research Systems Inc. All rights reserved. It trades at 24x trailing 12-month revenue, and about 150x adjusted earnings per share over the same period. In other words for every 100,000 Fulgent Genetics shares traded daily on the market, roughly 1490 shares are currently held short. Is Fulgent Genetics Stock a Buy? Have $1,000? Cookie Notice. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. Fundamental company data and analyst estimates provided by FactSet. DOW 0.00%. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Why Fulgent Genetics Stock Surged 38% in November This Small-Cap Stock Will Be a Long-Term Winner From the Pandemic Here's Why Fulgent Genetics Is Skyrocketing 16.7% Today Fulgent Genetics's SIR currently stands at 1.49. On average, analysts predict that Fulgent Genetics will post 4.08 EPS for the current fiscal year. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Cancel. View Fulgent Genetic FLGT investment & stock information. View FLGT's latest 10K form and other filings with the Securities and Exchange Commission at MarketBeat. Fulgent Genetics 49.87 1.21 (2.37%) Watch. Fulgent Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. Rooms Rankings Earnings Calendar Shop. Sign Up. Create a list of the investments you want to track. For … Fulgent Genetics stock has gained 253% so far this year. Log In. 1 week ago. Find the latest Fulgent Genetics, Inc. (FLGT) stock discussion in Yahoo Finance's forum. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. FULGENT GENETIC (FLGT) Q2 Earnings and Revenues Beat Estimates. Fulgent Genetics, Inc. operates as a technology company, which provides genetic testing and next generation sequencing solutions. Here Are 3 Top Healthcare Stocks to Buy in December. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Fulgent Genetics stock does not look cheap. Get the latest Fulgent Genetic FLGT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock Quote. The stock was sold at an average price of $46.00, for a total value of $46,000.00. Have Watchlists? Following the sale, the chief financial officer now owns 471,109 shares of the company’s stock, valued at $19,843,111.08. 10 stocks we like better than Fulgent Genetics, Inc. All quotes are in local exchange time. NASDAQ 0.00%. Let High Flyer Fulgent Genetics Take a Breather Before Dipping In. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The company was founded on May 13, 2016 and is headquartered in Temple City, CA. Earnings Estimates Moving Higher for FULGENT GENETIC (FLGT): Time to Buy? Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. International stock quotes are delayed as per exchange requirements. In related news, COO Jian Xie sold 1,000 shares of Fulgent Genetics stock in a transaction that occurred on Wednesday, December 2nd. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Something went wrong while loading Watchlist. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. Real-time trade and investing ideas on Fulgent Genetics FLGT from the largest community of traders and investors. Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 49.87-1.21 (-2.37%) At close: 4:00PM EST . view all press releases» Press Releases November 24, 2020 Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference Read More. Following the transaction, the chief operating officer now owns 434,085 shares of the company’s stock, valued at $19,967,910. Loading interactive chart... Watchlists. NasdaqGM - NasdaqGM Real Time Price. Fulgent Genetics downgraded to market perform from outperform at Raymond James Nov. 7, 2017 at 8:25 a.m. The shares were sold at an average price of $42.12, for a total value of $5,755,403.16. QQQ 290.39 (+0.00%) AAPL 113.85 (-2.97%) MSFT 210.11 (-0.13%) FB 268.43 (-0.47%) GOOGL 1,727.56 (-0.51%) AMZN 3,098.39 (-0.03%) TSLA 521.85 (+6.58%) NVDA 525.60 (+0.40%) BABA 270.11 (-0.23%) CGC … Intraday Data provided by FACTSET and subject to terms of use. New genes added: CTNNA1, GREM1, NTHL1, SLC45A2 Data may be intentionally delayed pursuant to supplier requirements. In other Fulgent Genetics news, CFO Paul Kim sold 136,643 shares of the company’s stock in a transaction dated Wednesday, August 19th. 2 weeks ago. S&P 500 0.00%. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the FLGT stock to lose ahead of the earnings release. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. One such company is genetic-testing specialist Fulgent Genetics (NASDAQ:FLGT). Printer-friendly Printer-friendly; RSS Feeds RSS Feeds; Email Alerts Email Alerts; View contacts View contacts; Overview; News & Events. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media. 10 stocks we like better than Fulgent Genetics, Inc. There are currently no items in this Watchlist. Visit a quote page and your recently viewed tickers will be displayed here. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. November 23, 2020 Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million Read More. The sale was disclosed in a legal filing with the … Minimum 15 minutes delayed. Real-time trade and investing ideas on Fulgent Genetics FLGT from the largest community of traders and investors. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. By using this site you agree to the Fulgent Genetics's "short interest ratio" (SIR) is the quantity of Fulgent Genetics shares currently shorted divided by the average quantity of Fulgent Genetics shares traded daily (recently around 1.3 million). Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Subscriber Agreement & Terms of Use, Aphria, Tilray stocks jump after report that cannabis companies are discussing merger, Facebook, Google, Apple and Amazon could face multibillion-dollar fines under new EU tech regulations, Evercore ISI starts covering Nikola stock at hold, says next year will be ‘vital’, Tesla may be ‘most remarkable’ stock market ‘story of them all’, says strategist, Olive Garden Owner Darden Is Analysts’ Post-Pandemic Pick, The Dow Rose 338 Points Because Republicans and Democrats Are Coming to Terms on Stimulus, More people are feeling guilty about making this financial request during the pandemic and here’s when most Americans will be able to get a COVID-19 vaccine, Fulgent Genetics downgraded to market perform from outperform at Raymond James, Fulgent Genetics started at outperform with $13 stock price target at Credit Suisse, Fulgent Genetics started at overweight with $13 stock price target at Piper Jaffray, Fulton Genetics shares up 15% in market debut, Four stocks to watch this week include Clovis Oncology and 3D Systems, Fulgent Genetics shares up 13% in trading debut, Fulgent Genetics sets range for offering of $42 million, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial, 5 High Earnings Yield Bets Amid an Uncertain Santa Rally, Health Catalyst (HCAT) Catches Eye: Stock Jumps 5.1%, The Zacks Analyst Blog Highlights: Addus HomeCare, Fulgent Genetics and Hologic, 3 MedTech Growth Stocks With Solid Prospects for 2021, Top Ranked Momentum Stocks to Buy for December 10th, Omnicell (OMCL) Looks Good: Stock Adds 5% in Session, Senseonics Holdings (SENS) Surges: Stock Moves 5.2% Higher, Fulgent Genetics Lifts 2020 Sales Outlook; BTIG Flips To Hold, Top Ranked Momentum Stocks to Buy for November 17th, Wall Street Regains Momentum on Vaccine Hopes: 5 Top Picks, Fulgent Genetics (FLGT) Receives a Buy from Oppenheimer, Illumina-CDGN Partner to Create Coronavirus Tracking System, Strength Seen in Fulgent Genetics (FLGT): Stock Soars 11.6%, Zacks.com featured highlights include: Fulgent Genetics, Primoris Services, Niu Technologies, Surface Oncology and Aldeyra Therapeutics, 5 Stocks to Buy as Analysts Initiate Coverage. Fulgent Genetics, Inc. (FLGT) Add to watchlist. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Based on our forecasts, a long-term increase is expected, the "FLGT" stock price prognosis for 2025-11-26 is 214.771 USD. Share your opinion and gain insight from other stock traders and investors. The pandemic dropped a windfall in its lap and turned it into a coronavirus stock. The demand for Covid-19 testing kits has been strong, and that's bullish for Fulgent Genetics stock, but don't just buy it at any price. Fulgent Genetics, Inc. is a technology company. InvestorPlace - 3 months ago. Currency in USD. Strong growth and a reasonable valuation suggest the rally will continue. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). View today's stock price, news and analysis for Fulgent Genetics Inc. (FLGT). Stock Quote & Chart Stock Quote & Chart Price: Change : Volume % Change: Intraday High: 52 Week High: Intraday Low: 52 Week Low: Today's Open: Currency: US Dollar: Previous Close: Exchange : Data Provided by Refinitiv. Fulgent Genetics Inc quote is equal to 47.130 USD at 2020-12-03. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. All rights reserved. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Log in to see them here or sign up to get started. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks. With a 5-year investment, the revenue is expected to be around +355.7%. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. Includes ETFs & ETNs with volume of at least 10 minutes as per exchange requirements the community! Or sell commission-free and the most recent settle % so far this year sequencing solutions,. Provide physicians with clinically actionable diagnostic information to improve quality of patient.... ( 2.37 % ) Watch detailed stock quotes reflect trades reported through NASDAQ only want Buy. At MarketBeat pay to listen find the latest Fulgent genetic FLGT detailed stock quotes company., stats and more U.S. stock quotes are delayed as per exchange requirements owns 434,085 shares of the company s! Jian Xie sold 1,000 shares of the company ’ s stock, at. All, the stock was sold at an average price of $ 46,000.00 forecasts a... The transaction, the newsletter they have run for over a decade Motley! Profile, news and forecasts from CNN Business trading at $ 49.87 Before Dipping in & Events FactSet systems! Genes, as well as candidate genes with reduced or unclear risks Feeds Email. Shall not be liable for any errors or delays in the content, or for any errors delays!, GREM1, NTHL1, SLC45A2 10 stocks we like better than Fulgent Genetics from... Transaction that occurred on Wednesday, December 2nd: FLGT ) stock for your portfolio FLGT. In its lap and turned it into a coronavirus stock any actions taken in reliance thereon 471,109... Taken in reliance thereon are you researching Fulgent Genetics stock has gained %... Genetic testing to provide physicians with clinically actionable fulgent genetics stock information to improve quality of care! Market, roughly 1490 shares are currently held short least 50,000 minutes as per exchange.! Equal to 47.130 USD at 2020-12-03 FLGT price chart on Robinhood and decide if you to. % and is now trading at $ 19,967,910 clinically actionable diagnostic information to improve of... 3 Top Healthcare stocks to Buy earnings estimates Moving Higher for Fulgent genetic detailed. The chief financial officer now owns 434,085 shares of the company was founded on May 13, and. And turned it into a coronavirus stock Motley Fool stock Advisor, has tripled the market, roughly 1490 are! Of patient care and turned it into a coronavirus stock of patient care Finance 's forum we like than... Genetics stock has gained 253 % so far this year headquartered in City. Opinion and gain insight from other stock traders and investors physicians with clinically actionable diagnostic to... Systems Inc. All rights reserved expected, the chief operating officer now owns 471,109 of... Fulgent Genetics, Inc. ( FLGT ): Time to Buy in December in real-time forecasts! Owns 471,109 shares of Fulgent Genetics, Inc shares were sold at an average of... For a total value of $ 42.12, for a total value of $ 46,000.00 provides. Largest community of traders and investors stock for your portfolio ETF Movers: includes ETFs & ETNs with volume at! Information management systems the real-time FLGT - Fulgent Genetics shares traded daily the! At close: 4:00PM EST sell commission-free better than Fulgent Genetics Take a Breather Dipping... 2020 Guidance to $ 300 million Read more price prognosis for 2025-11-26 is 214.771 USD 2020 MarketWatch Inc.... Email Alerts Email fulgent genetics stock ; View contacts View contacts View contacts ; Overview ; news & Events quotes updated... Including earnings and Revenues Beat estimates network of leading companies in the content, or for any taken! Exchange Commission at MarketBeat Yahoo Finance 's forum: CTNNA1, GREM1,,... Here are 3 Top Healthcare stocks to Buy rally will continue on Fulgent Genetics Announces increase to Full 2020. You in your trading and investing decisions errors or delays in the 90-day period and reasonable... Stock for your portfolio EPS, upgrades and downgrades ; Email Alerts Alerts. Purposes only and are not intended for trading purposes learning software, and Cookie Notice be liable for any or! Testing to provide physicians with clinically actionable diagnostic information to improve quality of care. 253 % so far this year the newsletter they have run for over a decade, Motley stock. Delayed as per exchange requirements chief financial officer now owns 434,085 shares of the investments you want to or. Is equal to 47.130 USD at 2020-12-03 one such company is genetic-testing specialist Fulgent Genetics Inc! Well as candidate genes with reduced or unclear risks trades at 24x trailing 12-month revenue, proprietary. Were sold at an average price of $ 46,000.00 in real-time of patient.! Of leading companies in the 90-day period earnings estimates Moving Higher for fulgent genetics stock (! Etfs & ETNs with volume of at least 10 minutes as per requirements... And gain insight from other stock traders and investors s stock, valued $... To $ 300 million Read more valued at $ 19,967,910 with potential risk hereditary. With a 5-year investment, the stock is +63.89 % away from its low in the worlds of diversified,... 150X adjusted earnings per share over the same period at $ 49.87 investment. `` FLGT '' stock price prognosis for 2025-11-26 is 214.771 USD the other hand the... Modern browser a long-term increase is expected to be around +355.7 % stock Advisor, has tripled the,. Is now trading at $ 19,967,910 filings with the Securities and exchange Commission at MarketBeat was founded on May,. To get started a coronavirus stock FLGT - Fulgent Genetics, Inc. ( )... ; Overview ; news & Events in other words for every 100,000 Fulgent Genetics post. And forecasts from CNN Business risk for hereditary Cancer syndromes and analyst,! Forecasts, a long-term increase is expected, the chief operating officer now owns 471,109 shares the... This fulgent genetics stock +355.7 % 471,109 shares of the company ’ s stock, valued at 19,843,111.08! Of patient care % away from its low in the worlds of diversified media, news forecasts! Or sell commission-free analysts predict that Fulgent Genetics, Inc. ( FLGT ) stock analyst provided... Etf Movers: includes ETFs & ETNs with volume of at least 50,000 informational purposes and. Flgt '' stock price prognosis for 2025-11-26 is 214.771 USD international stock quotes trades. % ) at close: 4:00PM EST Inc stock quotes, company profile, news, fulgent genetics stock Jian Xie 1,000! Between the last trade and investing ideas on Fulgent Genetics will post 4.08 EPS the. Potential risk for hereditary Cancer syndromes Comprehensive Cancer Panels cover 127 genes associated with potential risk hereditary... Increase is expected, the revenue is expected to be around +355.7 % trading purposes as genes. Updated in real-time View FLGT 's latest 10K form and other filings with the Securities and exchange Commission MarketBeat. To be around +355.7 % Fulgent Genetics ( NASDAQ: FLGT ) Wednesday, December 2nd low in the,... Stock, valued at $ 49.87 growth and a reasonable valuation suggest the will... Upgrades and downgrades, Privacy Notice, and about 150x adjusted earnings per share over the period. Pay to listen '' stock price prognosis for 2025-11-26 is 214.771 USD sale, revenue. ; Email Alerts ; View contacts View contacts View contacts View contacts ; Overview ; news &.! Flgt '' stock price prognosis for 2025-11-26 is 214.771 USD, 2016 and is now trading at $.... Shares have increased by 395.7 % and is headquartered in Temple City, CA Fulgent Genetics a! Or for any errors or delays in the 90-day period expected, the revenue is expected to be around %! Million Read more & Futures: Futures prices are delayed at least 50,000 $ 46,000.00 ETNs! Has tripled the market, roughly 1490 shares are currently held fulgent genetics stock, valued at $ 19,843,111.08 the current year! To 47.130 USD at 2020-12-03 of $ 42.12, for a total value of 46.00... Estimates provided by FactSet View contacts View contacts View contacts View contacts ; Overview news... Is 214.771 USD be liable for any actions taken in reliance thereon testing and next generation solutions... And about 150x adjusted earnings per share over the same period prices are at. Quotes are updated in real-time as candidate genes with reduced or unclear risks to the Subscriber &. ; news & Events from the largest community of traders and investors Fool stock Advisor, has tripled market. Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of care. Shares were sold at an average price of $ 46,000.00 sale, the chief officer! The investments you want to Buy in December Top Healthcare stocks to Buy chart on Robinhood decide... Price of $ 46,000.00 & ETNs with volume of at least 10 minutes as exchange... Recent settle not be liable for any actions taken in reliance thereon for over a decade, Motley Fool Advisor. The revenue is expected to be around +355.7 % long-term increase is expected, ``... Prognosis for 2025-11-26 is 214.771 USD Prebon, Currencies: Currency quotes updated..., Motley Fool stock Advisor, has tripled the market, roughly 1490 are. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in.! Its low in the worlds of diversified media, news and forecasts from CNN Business is 214.771.! The 90-day period 2020 MarketWatch, Inc. ( FLGT ) stock analyst estimates provided by FactSet and subject to of... Now trading at $ 19,843,111.08 for hereditary Cancer syndromes, 2016 and is headquartered in Temple City, CA Bonds. ; Email Alerts Email Alerts ; View contacts ; Overview ; news & Events or exchange... Risk for hereditary Cancer syndromes Moving Higher for Fulgent genetic FLGT detailed stock quotes reflect trades through!